Authors: EDDAHIBI S RAFFESTIN B DEGOUVILLE ACL ADNOT S

Citation: S. Eddahibi et al., EFFECT OF DMPPO, A PHOSPHODIESTERASE TYPE 5 INHIBITOR, ON HYPOXIC PULMONARY-HYPERTENSION IN RATS, British Journal of Pharmacology, 125(4), 1998, pp. 681-688

Authors: DELPY E COSTE H DEGOUVILLE ACL

Citation: E. Delpy et al., EFFECTS OF CYCLIC-GMP ELEVATION ON ISOPRENALINE-INDUCED INCREASE IN CYCLIC-AMP AND RELAXATION IN RAT AORTIC SMOOTH-MUSCLE - ROLE OF PHOSPHODIESTERASE-3, British Journal of Pharmacology, 119(3), 1996, pp. 471-478

Authors: DEGOUVILLE ACL COSTE H DELPY E

Citation: Acl. Degouville et al., CGMP-ELEVATING AGENTS POTENTIATE ISOPROTERENOL EFFECTS IN RAT AORTIC SMOOTH-MUSCLE - ROLE OF PDE-3, British Journal of Pharmacology, 118, 1996, pp. 14-14

Authors: DELPY E DEGOUVILLE ACL

Citation: E. Delpy et Acl. Degouville, CARDIOVASCULAR EFFECTS OF A NOVEL, POTENT AND SELECTIVE PHOSPHODIESTERASE-5 INHIBITOR, DMPPO - IN-VITRO AND IN-VIVO CHARACTERIZATION, British Journal of Pharmacology, 118(6), 1996, pp. 1377-1384

Authors: DEGOUVILLE ACL THIRY C CAVERO I

Citation: Acl. Degouville et al., DIFFERENTIAL INHIBITION OF THE PRESSER EFFECTS OF NATURAL PRO-ENDOTHELINS BY PHOSPHORAMIDON IN RATS, Fundamental and clinical pharmacology, 8(4), 1994, pp. 342-346